Pfizer Inc is moving into the gene therapy space in the latest sign that the technology for fixing faulty genes may finally be ready for prime time, following earlier setbacks.
Bayer AG
Breaking News
Pharma giants Novartis International AG and Merck & Co. Inc. are reportedly negotiating an asset trade of about $5 billion each. Novartis wants to exchange its animal health and human vaccines businesses for Merck's over-the-counter health products unit.
Despite the offer at a 27% premium from yesterday's trading close of Algeta ASA's shares, the Norwegian company said through a spokesperson that it does not guarantee that it will accept Bayer AG's offer.
Bayer AG purchases US contraceptive maker Conceptus.
